EMA
Medicine & Biotech · covered by 8 outlets this week · tracked since 2026-10-27
Press: 4 mainstream 14 specialist 3 independent outlet-days
Coverage
Celltrion's Steqeyma wins EU panel backing for broader pediatric use
Korea Biomedical Review · 2d ago
ittranslation pending
Sandoz: no all’esclusione di amoxicillina e amoxicillina/acido clavulanico dalla bozza dell’Elenco UE dei Medicinali Critici 2026. “Sono farmaci essenziali di prima linea”
Quotidiano Sanità · 3d ago
review
PRAC starts review of depression and anxiety medicine Deanxit (flupentixol/melitracen)
EMA News · 12d ago
EMA closed on All Souls' Day, 2 November
EMA News · 13d ago
EU-Vigil Flags 612 COVID Vaccine Safety Signals in European Data: What Has the EMA Investigated?
TrialSite News · 16d ago
AMA and EMA issue joint guidance on Ebola vaccine development
EMA News · 19d ago
svtranslation pending
Ännu ett piller för viktnedgång får tummen upp av EMA
Dagens Medicin · 26d ago
estranslation pending
Europa da luz verde a la pastilla diaria que eleva la esperanza de vida a los pacientes con cáncer de páncreas
El Mundo Salud · 27d ago
svtranslation pending
Grönt ljus för banbrytande läkemedel för pankreascancer
Dagens Medicin · 27d ago
EMA recommends authorisation of Rasonque for metastatic pancreatic cancer
EMA News · 27d ago
The regulatory door is ajar
Longevity.Technology · 30d ago
EMA Management Board: highlights of September 2026 meeting
EMA News · 41d ago
Executive Director speech at EMA women’s health multi-stakeholder workshop
EMA News · 41d ago
Women are missing from medicines development: EMA’s roadmap for change
EMA News · 42d ago
FDA/EMA meeting highlights challenges for botanical drugs
SupplySide Supplement Journal · 47d ago
detranslation pending
ERKLÄRT - In der Schweiz ist jetzt ein neuartiges Medikament gegen Alzheimer zugelassen: Was Donanemab wirklich kann
NZZ Wissenschaft · 279d ago
Major milestone for WHO-supported Ebola vaccine
WHO News · 2581d ago